BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $20M invested in Barinthus Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.71% less ownership
Funds ownership: 27.37% → 25.66% (-1.7%)
8% less capital invested
Capital invested by funds: $21.6M → $20M (-$1.65M)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$46.5K | |
| 2 | +$35K | |
| 3 | +$30.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.05K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$251 |